Mission of Sihuan
Innovation for human health
Enjoy the video
News and Events
Sihuan Metformin Hydrochloride Tablet Passes Consistency Evaluation
Sihuan Officially Starts Phase II Clinical Trial on Pirotinib in China
Che Fengsheng and His Team Visit Jiulongpo Hospital 2 for Work Guidance
Explore Sihuan Pharmaceutical
years of development
outstanding R&D personnel
Continuously dedicate substantial investment in R&D, which is conducted at our R&D platform with international standards, while establishing cooperation with international industry players.
As a key player in the healthcare industry, we have built a diversified product portfolio covering five major therapeutic areas: cardio-cerebral vascular system, central nervous system, metabolism, oncology and diabetes.